Impact of anti-CD20 monoclonal antibodies on serologic response to
Por um escritor misterioso
Descrição
Humoral serological response to the BNT162b2 vaccine is abrogated in lymphoma patients within the first 12 months following treatment with anti-CD2O antibodies
JPM, Free Full-Text
Impact of Rituximab and Host/Donor Fc Receptor Polymorphisms after Allogeneic Hematopoietic Cell Transplantation for CD20+ B Cell Malignancies - Biology of Blood and Marrow Transplantation
A broadly neutralizing macaque monoclonal antibody against the HIV-1 V3-Glycan patch
State of the CAR-T: Risk of Infections with Chimeric Antigen Receptor T-Cell Therapy and Determinants of SARS-CoV-2 Vaccine Responses - Transplantation and Cellular Therapy, Official Publication of the American Society for Transplantation
Vaccines, Free Full-Text
Establishment of C20Mab‑11, a novel anti‑CD20 monoclonal antibody, for the detection of B cells
Vaccines, Free Full-Text
Imaging the mechanisms of anti-CD20 therapy in vivo uncovers spatiotemporal bottlenecks in antibody-dependent phagocytosis
Antibodies, Free Full-Text
Long-lasting antitumor protection by anti-CD20 antibody through cellular immune response - ScienceDirect
Anti-CD20 monoclonal antibodies in chronic lymphocytic leukemia: from uncertainties to promises
Development of humoral and cellular immunological memory against SARS-CoV-2 despite B cell depleting treatment in multiple sclerosis - ScienceDirect
_20140516.jpg)
